The site of IGHS makes use of Cookies so that you can have the best user experience for all the functionalities, without collection of any personal info. By continuing you do accept our privacy policy.

KELO.CELL's remarkable participation at the Arab Health Exhibition 2024

KELO.CELL's remarkable participation at the Arab Health Exhibition 2024

The IGHS Group has achieved significant success in expanding business opportunities for the KELO.CELL brand in the highly competitive pharmaceutical sector. In a region where the IGHS has a strong reputation for the development and management of the Oman International Hospital in Muscat, the Portuguese Group's participation reinforces its position in the healthcare sector.

Focused on well-being, KELO.CELL had the opportunity to present new products of the Scar Care line, namely KELO.CELL Protect and KELO.CELL Scar Concealer, which will be launched in the markets this year. The PSORIS line, composed of SOS Acute Balm and Body Lotion, both essential for the treatment of psoriasis-prone skin, represents not only an innovative combination but has also received exceptionally positive feedback, marking it as a standout success this year.

It was a fantastic four days filled with meaningful conversations and new connections at the largest exhibition in the Middle East, which this year welcomed over 100 000 visitors from more than 180 countries. 
KELO.CELL has successfully fulfilled its mission by strengthening the connections established in this region and promoting collaborations with healthcare professionals, distributors, and sector leaders. 

If you weren't able to attend the exhibition this year, visit our website www.kelocell.com.